Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07899827Not yet recruiting
Randomised, open-label trial in Tobacco Use Disorder (TUD) (6 arms), sponsored by The Ohio State University Comprehensive Cancer Center – James Cancer Hospital. Primary endpoints: Plasma Nicotine Pharmacokinetics Maximum Concentration up to 1 month, Plasma Nicotine Pharmacokinetics Time to Maximum Concentration up to 1 month and 9 more. Planned start Jan 2027; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07899827.